Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.54 |
| ▸ | GABRD | O14764 | 2/20 | 0.54 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.54 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.54 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.54 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.54 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.54 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.54 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.54 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.54 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.54 |
| ▸ | GABRE | P78334 | 2/20 | 0.54 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.54 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.54 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.54 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.54 |
| ▸ | PPARA | Q07869 | 3/20 | 0.51 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.49 |
| ▸ | PPARG | P37231 | 2/20 | 0.48 |
| ▸ | KAT8 | Q9H7Z6 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9068780 | 0.98 | PPARA (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL6112733 | 0.98 | PPARA (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL9068637 | 0.98 | PPARA (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4327627 | 0.98 | PPARA (0.54) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL240794 | 0.95 | GABRP (0.59) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL31117550 | 0.95 | GABRP (0.59) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL343331 | 0.92 | ALDH1A1 (0.55) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL29632107 | 0.92 | ALDH1A1 (0.55) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL30833194 | 0.90 | MAPT (0.53) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1931833 | 0.88 | MAPT (0.52) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1595936-B1 | COMPOSITION FOR EXTERNAL USE | VITAMIN C60 BIORES CORP (JP) | 2011-10-19 | — | — | EP | claimed |
| US-20250057872-A1 | INNATE IMMUNOMODULATORY EFFECT OF GINSENG BERRY POLYSACCHARIDES IN IMMUNOCOMPROMISED CONDITIONS | Gangneung-Wonju National University Industry Academy Cooperation Group (KR) | 2025-02-20 | — | — | US | disclosed |
| US-20240285714-A1 | COMPOSITION FOR ANTI-INFLAMMATORY, ANTIOXIDANT, ANTI-WRINKLE OR HAIR HEALTH PROMOTION CONTAINING EXTRACT MIXTURE OF ZIZIPHUS JUJUBA MILLER, CITRUS UNSHIU PEEL AND ACORUS CALAMUS AS ACTIVE INGREDIENT | INDUSTRY-ACADEMIC COOPERATION FOUNDATION DAEGU HAANY UNIVERSITY (KR) | 2024-08-29 | — | — | US | disclosed |
| US-11518735-B2 | Pseudoceramide compound with improved stability and composition comprising same | AE KYUNG INDUSTRIAL CO., LTD. (KR) | 2022-12-06 | — | — | US | disclosed |
| US-20200354309-A1 | NOVEL PSEUDOCERAMIDE COMPOUND WITH IMPROVED STABILITY AND COMPOSITION COMPRISING SAME | AE KYUNG INDUSTRIAL CO., LTD (KR) | 2020-11-12 | — | — | US | disclosed |
| US-10722548-B2 | Method of preparing lyophilizate of Taheebo alcohol extract | COSMAX NBT, INC. (KR) | 2020-07-28 | — | — | US | disclosed |
| US-10695314-B2 | Antimicrobial composition containing 7,10-epoxyoctadeca-7,9-dienoic acid as active ingredient | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2020-06-30 | — | — | US | disclosed |
| US-20190167746-A1 | METHOD OF PREPARING LYOPHILIZATE OF TAHEEBO ALCOHOL EXTRACT | NUTRIBIOTECH (KR) | 2019-06-06 | — | — | US | disclosed |
| US-20190133989-A1 | ANTIMICROBIAL COMPOSITION CONTAINING 7,10-EPOXYOCTADECA-7,9-DIENOIC ACID AS ACTIVE INGREDIENT | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2019-05-09 | — | — | US | disclosed |
| US-10233143-B2 | Pseudoceramide compound, and external use skin preparation composition containing same | AE KYUNG INDUSTRIAL CO., LTD (KR) | 2019-03-19 | — | — | US | disclosed |
| US-20160303146-A1 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT NEUROINFLAMMATORY DISORDERS | TABACZYNSKI DAVID A (US) | 2016-10-20 | — | — | US | disclosed |
| WO-2015089349-A1 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT NEUROINFLAMMATORY DISORDERS | TABACZYNSKI DAVID A (US) | 2015-06-18 | — | — | WO | disclosed |
| WO-2015084721-A1 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT AUTOIMMUNE DISORDERS | TABACZYNSKI DAVID A (US) | 2015-06-11 | — | — | WO | disclosed |
| US-8747816-B2 | UV-photoprotective compositions comprising diebenzoylmethane screening agents and silicon-containing s-triazine compounds substituted with two aminobenzoate or aminobenzamide groups | L'OREAL (FR) | 2014-06-10 | — | — | US | disclosed |
| US-20120129838-A1 | Composition for Preventing and Treating Alopecia Disorder Containing Morgalanthamine Compounds as an Active Ingredient | THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (KR) | 2012-05-24 | — | — | US | disclosed |
| US-20080145324-A1 | UV-photoprotective compositions comprising diebenzoylmethane screening agents and silicon-containing s-triazine compounds substituted with two aminobenzoate or aminobenzamide groups | L'OREAL (FR) | 2008-06-19 | — | — | US | disclosed |
| US-5482986-A | ULTRAVIOLET RADIATION ABSORBER FOR THERMOPLASTIC RESINS; COLORLESS, HEAT RESISTANCE | MITSUI TOATSU CHEMICALS, INC. (JP) | 1996-01-09 | — | — | US | disclosed |
| EP-0635504-A1 | Benzopyran compound and use of the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-RE28806-E | Liquid crystal compositions | XEROX CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
| US-3931041-A | LIQUID CRYSTAL COMPOSITIONS | XEROX CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120129838-A1 | Composition for Preventing and Treating Alopecia Disorder Containing Morgalanthamine Compounds as an Active Ingredient | MITF, GLA, GALNT3 | GABRP 4401/4885GABRD 3493/4885GABRA1 4008/4885 |
| US-20080145324-A1 | UV-photoprotective compositions comprising diebenzoylmethane screening agents and silicon-containing s-triazine compounds substituted with two aminobenzoate or aminobenzamide groups | TST, TYR, DDT | GABRP 3329/4885GABRD 2455/4885GABRA1 3346/4885 |
| US-11518735-B2 | Pseudoceramide compound with improved stability and composition comprising same | CERS2, ASAH2, ASAH1 | GABRP 4619/4885GABRD 4836/4885GABRA1 4770/4885 |
| US-20200354309-A1 | NOVEL PSEUDOCERAMIDE COMPOUND WITH IMPROVED STABILITY AND COMPOSITION COMPRISING SAME | CERS2, ASAH2, CERT1 | GABRP 4566/4885GABRD 4835/4885GABRA1 4746/4885 |
| US-10695314-B2 | Antimicrobial composition containing 7,10-epoxyoctadeca-7,9-dienoic acid as active ingredient | CYP51A1, IL17A, ELOVL5 | GABRP 3054/4885GABRD 978/4885GABRA1 2857/4885 |
| US-20160303146-A1 | INHIBITION OF ISOPRENOID BIOSYNTHETIC PATHWAYS TO TREAT NEUROINFLAMMATORY DISORDERS | GGPS1, FDPS, COASY | GABRP 1928/4885GABRD 2651/4885GABRA1 2694/4885 |
| US-20190133989-A1 | ANTIMICROBIAL COMPOSITION CONTAINING 7,10-EPOXYOCTADECA-7,9-DIENOIC ACID AS ACTIVE INGREDIENT | CYP51A1, IL17A, ELOVL5 | GABRP 3054/4885GABRD 978/4885GABRA1 2857/4885 |
| US-10233143-B2 | Pseudoceramide compound, and external use skin preparation composition containing same | CERS2, CERT1, ACER2 | GABRP 3953/4885GABRD 4747/4885GABRA1 4437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.